Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IKT Inhibikase Therapeutics

Watchlist
0.574
-0.026-4.33%
Close 12/02 16:00 ET
0.5740.0000.00%
Post Mkt Price 12/02 16:31 ET
High
0.668
Open
0.658
Turnover
6.19K
Low
0.561
Pre Close
0.600
Volume
10.51K
Market Cap
14.48M
P/E(TTM)
Loss
52wk High
1.800
Shares
25.23M
P/E(Static)
Loss
52wk Low
0.440
Float Cap
10.50M
Bid/Ask %
50.00%
Historical High
11.800
Shs Float
18.29M
Volume Ratio
0.55
Historical Low
0.440
Dividend TTM
--
Div Yield TTM
--
P/B
0.58
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.06%
Amplitude
17.82%
Avg Price
0.589
Lot Size
1
Float Cap
10.50M
Bid/Ask %
50.00%
Historical High
11.800
Shs Float
18.29M
Volume Ratio
0.55
Historical Low
0.440
Dividend TTM
--
P/B
0.58
Dividend LFY
--
Turnover Ratio
0.06%
Amplitude
17.82%
Avg Price
0.589
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMP? Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
CEO: Dr. Milton H. Werner, PhD
Market: NASDAQ
Listing Date: 12/23/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist